EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells

Ni Wang iD, Qing Lin, Huimin Fan, Yixuan Wang, Chang Shu, Na Wang, Dazhi Zhang

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Ni Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis…. Hauptthemen laut MEDLINE: COVID-19, HIV Infections, SARS-CoV-2, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This work was supported by the COVID-19 Emergency Response Project in 2022 (2023IIT×G12), a Remarkable Innovation-Clinical Research Project and the DengFeng Pr….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical manifestations of variability in PLWH with SARS‐CoV‐2 acquired may be attributed to the use of ART drugs. Omicron breakthrough infection and reinfection in 27 PLWH treated with BIC/FTC/TAF and 51 PLWH treated with TDF/3TC/EFV were investigated, and humoral and cellular immunity after Omicron breakthrough infection were also compared. The results showed that Omicron breakthrough infection symptoms in BIC/FTC/TAF‐treated had a shorter duration, and BIC/FTC/TAF could further reduce the duration of symptoms when re‐infected. It was also found that the BA.5 specific IgG titers of BIC/FTC/TAF‐treated were significantly increased and increased with the extension of the duration of BIC/FTC/TAF. In cellular immunity, the use of BIC/FTC/TAF was also found to increase not only BA.5‐specific B lymphocytes and BA.5‐specific CD4 + T lymphocytes, but also total CD4 + T cells. In conclusion, compared to TDF/3TC/EFV, BIC/FTC/TAF can help PLWH shorten the duration of COVID − 19 symptoms, enhance SARS‐CoV‐2 specific humoral and cellular immune responses, help to expand the total CD4 + T cells increase in PLWH after Omicron infection and may be more beneficial for PLWH with high risk of infection in the context of COVID‐19 normalization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HIV InfectionsSARS-CoV-2CD4-Positive T-LymphocytesAntibodies, ViralHumansMaleFemaleAdultMiddle AgedCD4 Lymphocyte CountImmunity, CellularAnti-HIV AgentsImmunity, HumoralImmunoglobulin GBreakthrough Infections

Stichwörter der Autor:innen

BIC/FTC/TAFCD4 cellsHIVimmune responseomicronsymptoms

Substanzen

Antibodies, ViralAnti-HIV AgentsImmunoglobulin G

Autor:innen und Institutionen

  • Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongq…
  • Department of Infectious Diseases, The People's Hospital of Jiulongpo District, Chongqing, China.
  • Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Ni Wang

Förderung

  • This work was supported by the COVID-19 Emergency Response Project in 2022 (2023IIT×G12), a Remarkable Innovation-Clinical Research Project and the DengFeng Pr…

Zitieren

APA

Wang, N., Lin, Q., Fan, H., Wang, Y., Shu, C., Wang, N., & Zhang, D. (2024). BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells. Journal of Medical Virology. https://doi.org/10.1002/jmv.70036

Vancouver

Wang N, Lin Q, Fan H, Wang Y, Shu C, Wang N, et al. BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells. Journal of Medical Virology. 2024. doi:10.1002/jmv.70036

BibTeX
@article{Wang2024,
  author = {Wang, Ni and Lin, Qing and Fan, Huimin and Wang, Yixuan and Shu, Chang and Wang, Na and Zhang, Dazhi},
  title = {BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70036}
}
Kostenlos starten →